Publications by authors named "Guerin Mathilde"

Claim this Profile
T
The plasma nanoDSF denaturation profiles predict the presence of breast cancer.
Mathilde Guerin, Rémi Eyraud, Philippe Tsvetkov, Pascal Finetti, Alexandre Giraudo

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
Arthur Géraud, Paul Gougis, Alexandre de Nonneville, Mathilde Beaufils, François Bertucci, Mathilde Guerin

Cancer Treat Rev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
Clément Klein, Serge Brunelle, Mathias Illy, Valeria De Luca, Laure Doisy, Mathilde Guérin

World J Urol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Pot Synthesis of Bioinspired Peptide-Decorated Apatite Nanoparticles for Nanomedicine.
Mathilde Guérin, Aurélien Lebrun, Liisa Kuhn, Thierry Azaïs, Guillaume Laurent

Small· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifunctional Aluminum Pre-treatments from End-Functionalized Phosphonic Acid Self-Assembled Monolayers.
Reuben J Yeo, Julian N Bleich, Mathilde Guérin, Daniela Morganella, Michèle Berner

Langmuir· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.
Roxane Mari, Mathilde Guerin, Cécile Vicier, Jochen Walz, Nathalie Bonnet

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
Maelle Rony, Jean-Philippe Ratone, Jochen Walz, Geraldine Pignot, Fabrice Caillol, Mathilde Guerin

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.
Renaud Sabatier, Johan Martin, Cécile Vicier, Mathilde Guérin, Audrey Monneur

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Metastases From Primary Renal Cell Cancer: A Single Center Review.
Rony Maelle, Ratone Jean-Philippe, Walz Jochen, Pignot Geraldine, Caillol Fabrice, Guerin Mathilde

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic hormone sensitive prostate cancer: local treatment strategies.
Jochen Walz, Geraldine Pignot, Sami Fakhfakh, Jennifer Campagna, Mathilde Guerin

World J Urol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
Marine Sroussi, Reza Elaidi, Aude Fléchon, Marianne Lorcet, Delphine Borchiellini, Mathilde Guérin

Clin Genitourin Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.
Essia Mezni, Cécile Vicier, Mathilde Guerin, Renaud Sabatier, François Bertucci

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma.
Emilien Billon, Jochen Walz, Serge Brunelle, Jeanne Thomassin, Naji Salem, Mathilde Guerin

Front Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, Emilie Baudelet, Matthieu Pophillat

Oncotarget· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Mathilde Guerin, Keyvan Rezai, Nicolas Isambert, Mario Campone, Aurélie Autret

Eur J Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How may targeted proteomics complement genomic data in breast cancer?
Mathilde Guerin, Anthony Gonçalves, Yves Toiron, Emilie Baudelet, Stéphane Audebert

Expert Rev Proteomics· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.
Mathilde Guerin, Chaonan Qian, Qian Zhong, Qian Cui, Yunmiao Guo

Sci China Life Sci· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
Christine Pasero, Gwenaëlle Gravis, Mathilde Guerin, Samuel Granjeaud, Jeanne Thomassin-Piana

Cancer Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.
Christine Pasero, Gwenaëlle Gravis, Samuel Granjeaud, Mathilde Guerin, Jeanne Thomassin-Piana

Oncotarget· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Trastuzumab emtansine (Kadcyla(®)) approval in HER2-positive metastatic breast cancers].
Mathilde Guerin, Renaud Sabatier, Anthony Gonçalves

Bull Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up.
Mathilde Guerin, Naji Salem, Jochen Walz, Slimane Dermeche, Gwenaelle Gravis

World J Surg Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis